1. Prognostic differences in 8th edition TNM staging of esophagogastric adenocarcinoma after neoadjuvant treatment. Issue 10 (October 2018) Authors: Sisic, Leila; Blank, Susanne; Nienhüser, Henrik; Dorr, Sara; Haag, Georg Martin; Jäger, Dirk; Bruckner, Thomas; Müller-Stich, Beat P.; Ott, Katja; Büchler, Markus W.; Ulrich, Alexis; Schmidt, Thomas Journal: European journal of surgical oncology Issue: Volume 44:Issue 10(2018) Page Start: 1646 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Prognostic implication of molecular subtypes and response to neoadjuvant chemotherapy in 760 gastric carcinomas: role of Epstein–Barr virus infection and high‐ and low‐microsatellite instability. (17th June 2019) Authors: Kohlruss, Meike; Grosser, Bianca; Krenauer, Marie; Slotta‐Huspenina, Julia; Jesinghaus, Moritz; Blank, Susanne; Novotny, Alexander; Reiche, Magdalena; Schmidt, Thomas; Ismani, Liridona; Hapfelmeier, Alexander; Mathias, Daniel; Meyer, Petra; Gaida, Matthias M; Bauer, Lukas; Ott, Katja; Weichert, W... Journal: Journal of pathology Issue: Volume 5:Number 4(2019) Page Start: 227 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. The postoperative part of perioperative chemotherapy fails to provide a survival benefit in completely resected esophagogastric adenocarcinoma. (June 2020) Authors: Sisic, Leila; Blank, Susanne; Nienhüser, Henrik; Haag, Georg Martin; Jäger, Dirk; Bruckner, Tom; Ott, Katja; Schmidt, Thomas; Ulrich, Alexis Journal: Surgical oncology Issue: Volume 33(2020) Page Start: 177 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Germline variation in the insulin-like growth factor pathway and risk of Barrett's esophagus and esophageal adenocarcinoma. (10th December 2020) Authors: Dighe, Shruti G; Chen, Jianhong; Yan, Li; He, Qianchuan; Gharahkhani, Puya; Onstad, Lynn; Levine, David M; Palles, Claire; Ye, Weimin; Gammon, Marilie D; Iyer, Prasad G; Anderson, Lesley A; Liu, Geoffrey; Wu, Anna H; Dai, James Y; Chow, Wong-Ho; Risch, Harvey A; Lagergren, Jesper; Shaheen, Nichol... Journal: Carcinogenesis Issue: Volume 42:Number 3(2021) Page Start: 369 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. The Barrett‐associated variants at GDF7 and TBX5 also increase esophageal adenocarcinoma risk. (18th January 2016) Authors: Becker, Jessica; May, Andrea; Gerges, Christian; Anders, Mario; Schmidt, Claudia; Veits, Lothar; Noder, Tania; Mayershofer, Rupert; Kreuser, Nicole; Manner, Hendrik; Venerito, Marino; Hofer, Jan‐Hinnerk; Lyros, Orestis; Ahlbrand, Constantin J.; Arras, Michael; Hofer, Sebastian; Heinrichs, Sophie ... Journal: Cancer medicine Issue: Volume 5:Number 5(2016:May) Page Start: 888 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Post‐neoadjuvant assessment of tumour budding according to ITBCC subgroups delivers stage‐ and regression‐grade independent prognostic information in intestinal‐type gastric adenocarcinoma. (17th June 2022) Authors: Jesinghaus, Moritz; Herz, Anna‐Lina; Kohlruss, Meike; Silva, Miguel; Grass, Albert; Lange, Sebastian; Novotny, Alexander; Ott, Katja; Schmidt, Thomas; Gaida, Matthias; Hapfelmeier, Alexander; Denkert, Carsten; Weichert, Wilko; Keller, Gisela Journal: Journal of pathology Issue: Volume 8:Number 5(2022) Page Start: 448 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Immediate tumor resection in patients with locally advanced gastroesophageal adenocarcinoma with nonresponse to chemotherapy after 4 weeks of treatment versus resection after completion of chemotherapy (OPTITREAT trial, DRKS00004668): study protocol for a randomized controlled pilot trial. Issue 1 (December 2016) Authors: Blank, Susanne; Knebel, Phillip; Haag, Georg-Martin; Bruckner, Thomas; Klaiber, Ulla; Burian, Maria; Schaible, Anja; Sisic, Leila; Schmidt, Thomas; Diener, Markus; Ott, Katja Journal: Pilot and feasibility studies Issue: Volume 2:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Expression of class I histone deacetylases (HDAC1 and HDAC2) in oesophageal adenocarcinomas: an immunohistochemical study. Issue 11 (5th October 2010) Authors: Langer, Rupert; Mutze, Kathrin; Becker, Karen; Feith, Marcus; Ott, Katja; Höfler, Heinz; Keller, Gisela Journal: Journal of clinical pathology Issue: Volume 63:Issue 11(2010) Page Start: 994 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Supportive evidence for FOXP1, BARX1, and FOXF1 as genetic risk loci for the development of esophageal adenocarcinoma. (15th August 2015) Authors: Becker, Jessica; May, Andrea; Gerges, Christian; Anders, Mario; Veits, Lothar; Weise, Katharina; Czamara, Darina; Lyros, Orestis; Manner, Hendrik; Terheggen, Grischa; Venerito, Marino; Noder, Tania; Mayershofer, Rupert; Hofer, Jan‐Hinnerk; Karch, Hans‐Werner; Ahlbrand, Constantin J.; Arras, Micha... Journal: Cancer medicine Issue: Volume 4:Number 11(2015:Nov.) Page Start: 1700 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Significance of tumour regression in lymph node metastases of gastric and gastro‐oesophageal junction adenocarcinomas. (13th May 2020) Authors: Reim, Daniel; Novotny, Alexander; Friess, Helmut; Slotta‐Huspenina, Julia; Weichert, Wilko; Ott, Katja; Dislich, Bastian; Lorenzen, Sylvie; Becker, Karen; Langer, Rupert Journal: Journal of pathology Issue: Volume 6:Number 4(2020) Page Start: 263 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗